Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of inactivated Vero cell culture-derived Japanese encephalitis vaccine after hematopoietic stem cell transplantation
TCTR20191104001Phase 4Completed
- Sponsor
- Faculty of Medicine Ramathibodi Hospital, Mahidol University
- Start
- Jan 2016
- Countries
- 1
01
Overview
Phase 4, single-arm trial in Japanese encephalitis (JE), sponsored by Faculty of Medicine Ramathibodi Hospital, Mahidol University. Primary endpoint: Immunogenicity. Started Jan 2016; status: completed.
02
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on TCTR20191104001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191104001.